8 results about "Camptotheca acuminata" patented technology

This invention discloses a pharmaceutical composition and its preparation method for treating atrophic gastritis, precancerous lesions of the stomach, and stomach cancer, belonging to the field of traditional Chinese medicine preparation technology. The pharmaceutical composition is prepared by a specific two-step microbial fermentation process using Astragalus membranaceus, Hericium erinaceus, Curcuma zedoaria, Actinidia chinensis root, Camptotheca acuminata fruit, Hedyotis diffusa, Coptis chinensis, Taraxacum mongolicum, Viola yedoensis, Corydalis yanhusuo (processed with vinegar), Phellodendron chinense, Solanum nigrum, Scutellaria baicalensis, Panax notoginseng, Zingiber officinale, Piper cubeba, Cuttlebone, Fritillaria thunbergii, roasted soybean, and red yeast rice. This invention significantly improves the bioavailability of the active pharmaceutical ingredients through the synergistic effect of the multifunctional groups of traditional Chinese medicine and the enhanced effect of microbial fermentation. It can systematically reverse gastric mucosal atrophy and intestinal metaplasia, effectively improve microcirculation, and inhibit Helicobacter pylori, while also exhibiting good safety. This provides a novel and effective treatment for the aforementioned gastric diseases.

The application belongs to the field of Zhuang and Yao medicine treatment of acute ischemic stroke, and discloses a Zhuang and Yao medicine compound medicine, a preparation method and application thereof in treating acute ischemic stroke. The Zhuang and Yao medicine compound medicine comprises the following raw materials in parts by weight: Ficus tikoua 55-62 parts, Camptotheca acuminata 12-17 parts, Ilex hainanensis 26-35 parts and Saposhnikovia divaricata 13-18 parts. The four raw materials are put into clean water, and the raw materials are prepared into a medicinal liquid to obtain the Zhuang and Yao medicine compound medicine. The Zhuang and Yao medicine compound medicine is cheap, convenient to use, has remarkable curative effect, can dredge the dragon road and the toxic evil and toxic side effects of the fire road, and has a simple preparation process.

The application belongs to the technical field of traditional Chinese medicine, and specifically discloses a traditional Chinese medicine preparation for treating sepsis and a preparation method thereof. The traditional Chinese medicine preparation comprises the following raw materials in parts by weight: Fructus camptothecae 20-25 parts, Semen persicae 15-20 parts, Pericarpium trichosanthis 10-15 parts, Elatostema umbellatum 12-15 parts, Radix baiyuan 10-15 parts, Radix codonopsis 6-10 parts, Semen amygdali 5-10 parts, Radix notoginseng 6-10 parts, and Radix glycyrrhizae 4-8 parts. The traditional Chinese medicine preparation provided by the application has a reasonable prescription, and the monarch, the minister, the assistant and the messenger complement each other. In the prescription, Fructus camptothecae and Semen persicae are used as monarch drugs to play the efficacy of promoting blood circulation and removing blood stasis; Pericarpium trichosanthis, Elatostema umbellatum and Radix baiyuan are used as minister drugs, which, in combination with the monarch drugs, can play the efficacy of clearing heat and detoxifying while enhancing the efficacy of promoting blood circulation and removing blood stasis; Radix codonopsis, Radix notoginseng and Semen amygdali are used as assistant drugs to tonify the middle and replenish qi and blood, and Radix glycyrrhizae is used as messenger drug to harmonize various drugs, guide drugs into channels, and expel evil. The whole prescription has a reasonable compatibility, and has a good therapeutic effect on sepsis.

The invention discloses a Kangpu tea fermentation device, relates to the technical field of fermentation engineering, and is characterized in that a fixed plate is mounted at the upper end of a fermentation cavity of a fermentation tank body. The upper space of the fermentation cavity is separated by the fixed plate, and a gas collection chamber is formed on one side, far away from the fermentation cavity, of the fixed plate. And a gas guide piece, a sealing cylinder, a transmission structure and a cleaning plate are arranged on the gas collection chamber. A plurality of vent holes are formed in the fixed plate and are used for communicating the fermentation cavity below with the gas collection cavity above. One end, close to the fermentation cavity, of each vent hole is provided with an energy storage part which is telescopic based on gas pressure, and one end, relatively close to the gas collection cavity, of each vent hole is provided with a slidable sealing cover. The energy storage part is used for sensing the air pressure change in the fermentation cavity and driving the sealing cover, so that the opening and closing of the vent hole are controlled. According to the invention, the cleaning plate is driven based on discharged gas to automatically scrape mycoderm and sediment attached to the tank wall, so that the self-cleaning function of the fermentation device is realized.

This invention discloses a method for preparing a seven-membered cucurbita supramolecular cocrystal solvent and its application. The invention uses a seven-membered cucurbita as a hydrogen bond acceptor and malic acid as a hydrogen bond donor to prepare a seven-membered cucurbita supramolecular cocrystal solvent. This solvent can be used to extract camptothecin from Camptotheca acuminata fruit, and the extracted camptothecin can be determined by HPLC. This seven-membered cucurbita supramolecular cocrystal solvent is a green extraction solvent that does not use organic solvents when extracting active ingredients from plants, while the extracted active ingredients retain their intrinsic activity. The preparation method is simple, the extraction efficiency is high, and efficient, green extraction is achieved.

The present application relates to the technical field of natural product extraction and enrichment, and particularly relates to a method for extracting and enriching camptothecin (CPT) and 10-hydroxyl camptothecin (HCPT). The method solves the problems of low efficiency, poor safety, high cost and the like of common technologies. Dry camptothecin tissue powder and non-ionic surfactant Genapol X-080 are mixed according to a certain solid-liquid ratio, and then are placed in an extraction device for extraction. After extraction, CPT and HCPT extraction liquid is obtained through centrifugation. Inorganic salt is added to the extraction liquid at a certain temperature, and is uniformly stirred. The solution is subjected to directional enrichment treatment for a certain time, and is subjected to centrifugation or standing to separate the solution into layers. The upper surfactant-rich phase is taken, and the enrichment product of the CPT and HCPT extraction liquid is obtained. The extraction and enrichment process of the present application does not use any organic solvent, and is low in cost, safe and reliable, has high economic and environmental benefits, and has a good popularization and application prospect. The method has important significance for the industrialized safe production of CPT and HCPT.

The present application relates to the field of plant tissue culture, and particularly discloses a high-efficiency in-vitro accumulation method of camptothecin. The present application uses young stem segments of camptotheca acuminata as explants, and induces accumulation of camptothecin in camptotheca acuminata whole plants through the steps of bud induction, adventitious bud induction, camptothecin in-vitro enrichment phase I culture, camptothecin in-vitro enrichment phase II culture, camptothecin in-vitro enrichment phase III culture, and adventitious root camptothecin in-vitro enrichment, thereby establishing a high-efficiency in-vitro accumulation method of camptothecin. The method of the present application can produce camptothecin under in-vitro conditions, and meets the requirements of season-unrestricted production of camptothecin, land saving, and natural camptothecin without toxic and side residues.

This invention provides an application of the camptothecin oxygen methyltransferase CaOMT3 in catalyzing the oxygen methylation modification of hydroxycamptothecin and quercetin. Through transcriptomic and genomic analysis, four oxygen methyltransferases (CaOMT3) were identified. BECAUSE OF Genes were found to be clustered together; further analysis of metabolite and transcriptome co-expression revealed a gene significantly positively correlated with rhamnine accumulation. BECAUSE OF Genes, that is CaOMT3 Biochemical functional verification showed that CaOMT1, CaOMT2, and CaOMT3 can all catalyze the reaction of 9- and 10-hydroxycamptothecin. O Methylation yields the corresponding methoxycamptothecin. When quercetin is used as a substrate, CaOMT1 and CaOMT3 exhibit bifunctional catalytic activity, capable of simultaneously catalyzing the methylation of the 4'- and 7'-hydroxyl sites. O α-methylation yields rhamnosin, tamarindin, and phytoflavin; while CaOMT2 only catalyzes the 4'-hydroxyl site. Enzymatic kinetic analysis showed that CaOMT3's catalytic efficiency for quercetin ( k cat / K (m) is the highest. This invention provides a new enzyme tool and technological foundation for the synthetic biology research and industrial fermentation production of rhamnine and methoxycamptothecin.